Abstract
Epigenetics is now being heralded as a science that can bring change with momentous potential. The development and maintenance of any organism is formulated by certain chemical reactions that modulate parts of the genome at specific intervals involving the remodeling of chromatin. Understanding how chromatin remodeling can selectively activate or inactivate genes and subsequently influence pathogenesis and the outcome of many diseases becomes critical. Epigenetics provides us with the perception to look into the genetic process, the biological role of chromatin-associated proteins, and how alterations in epigenetic factors have majorly impacted human disease and development.
Modern views on epigenetic regulation driving the current attention of researchers in academia and industry are focused toward understanding epigenetic alterations implicated in maintenance of diverse biological processes such as DNA methylation, posttranslational histone tail modifications (PTMs), noncoding RNA control of chromatin structure, and nucleosome remodeling. Methylation of histones has associated with chromatin since long, and the histone methyltransferases since their discovery have been tied solely to chromatin structure and function by influencing transcriptional activation and repression in mammalian cells. Targeting these enzymes tied to histone methylation involved in many debilitating diseases like cancer by designing small-molecule inhibitors against them has shown potential as promising modes of therapy and treatment. This chapter will highlight the central roles of histone methyltransferases as potent epigenetic regulators modulating transcription and how their perturbations have severe repercussions in human disease and development particularly affecting cellular pluripotency and differentiation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Bibliography
Zentner GE, Henikoff S (2013) Regulation of nucleosome dynamics by histone modifications. Nat Struct Mol Biol 20(3):259–266
Huang H, Sabari BR, Garcia BA, Allis CD, Zhao Y (2014) SnapShot: histone modifications. Cell 159(2):458–4e1
Bannister AJ, Kouzarides T (2011) Regulation of chromatin by histone modifications. Cell Res 21(3):381–395
Biel M, Wascholowski V, Giannis A (2005) Epigenetics--an epicenter of gene regulation: histones and histone-modifying enzymes. Angew Chem 44(21):3186–3216
Lu X, Simon MD, Chodaparambil JV, Hansen JC, Shokat KM, Luger K (2008) The effect of H3K79 dimethylation and H4K20 trimethylation on nucleosome and chromatin structure. Nat Struct Mol Biol 15(10):1122–1124
Ringrose L, Paro R (2004) Epigenetic regulation of cellular memory by the Polycomb and Trithorax group proteins. Annu Rev Genet 38:413–443
Tschiersch B, Hofmann A, Krauss V, Dorn R, Korge G, Reuter G (1994) The protein encoded by the Drosophila position-effect variegation suppressor gene Su(var)3-9 combines domains of antagonistic regulators of homeotic gene complexes. EMBO J 13(16):3822–3831
Jones RS, Gelbart WM (1993) The Drosophila Polycomb-group gene Enhancer of zeste contains a region with sequence similarity to trithorax. Mol Cell Biol 13(10):6357–6366
Stassen MJ, Bailey D, Nelson S, Chinwalla V, Harte PJ (1995) The Drosophila trithorax proteins contain a novel variant of the nuclear receptor type DNA binding domain and an ancient conserved motif found in other chromosomal proteins. Mech Dev 52(2-3):209–223
Rea S, Eisenhaber F, O’Carroll D, Strahl BD, Sun ZW, Schmid M et al (2000) Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature 406(6796):593–599
Nguyen AT, Zhang Y (2011) The diverse functions of Dot1 and H3K79 methylation. Genes Dev 25(13):1345–1358
Ruthenburg AJ, Li H, Patel DJ, Allis CD (2007) Multivalent engagement of chromatin modifications by linked binding modules. Nat Rev Mol Cell Biol 8(12):983–994
Lachner M, O’Carroll D, Rea S, Mechtler K, Jenuwein T (2001) Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature 410(6824):116–120
Jacobs SA, Taverna SD, Zhang Y, Briggs SD, Li J, Eissenberg JC et al (2001) Specificity of the HP1 chromo domain for the methylated N-terminus of histone H3. EMBO J 20(18):5232–5241
Huyen Y, Zgheib O, Ditullio RA Jr, Gorgoulis VG, Zacharatos P, Petty TJ et al (2004) Methylated lysine 79 of histone H3 targets 53BP1 to DNA double-strand breaks. Nature 432(7015):406–411
Bannister AJ, Zegerman P, Partridge JF, Miska EA, Thomas JO, Allshire RC et al (2001) Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain. Nature 410(6824):120–124
Maurer-Stroh S, Dickens NJ, Hughes-Davies L, Kouzarides T, Eisenhaber F, Ponting CP (2003) The Tudor domain ‘Royal Family’: Tudor, plant Agenet, Chromo, PWWP and MBT domains. Trends Biochem Sci 28(2):69–74
Collins RE, Northrop JP, Horton JR, Lee DY, Zhang X, Stallcup MR et al (2008) The ankyrin repeats of G9a and GLP histone methyltransferases are mono- and dimethyllysine binding modules. Nat Struct Mol Biol 15(3):245–250
Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z et al (2007) High-resolution profiling of histone methylations in the human genome. Cell 129(4):823–837
Lee JS, Smith E, Shilatifard A (2010) The language of histone crosstalk. Cell 142(5):682–685
Qian C, Zhou MM (2006) SET domain protein lysine methyltransferases: Structure, specificity and catalysis. Cell Mol Life Sci 63(23):2755–2763
Richon VM, Johnston D, Sneeringer CJ, Jin L, Majer CR, Elliston K et al (2011) Chemogenetic analysis of human protein methyltransferases. Chem Biol Drug Des 78(2):199–210
Schubert HL, Blumenthal RM, Cheng X (2003) Many paths to methyltransfer: a chronicle of convergence. Trends Biochem Sci 28(6):329–335
Dillon SC, Zhang X, Trievel RC, Cheng X (2005) The SET-domain protein superfamily: protein lysine methyltransferases. Genome Biol 6(8):227
Martin C, Zhang Y (2005) The diverse functions of histone lysine methylation. Nat Rev Mol Cell Biol 6(11):838–849
Krogan NJ, Kim M, Tong A, Golshani A, Cagney G, Canadien V et al (2003) Methylation of histone H3 by Set2 in Saccharomyces cerevisiae is linked to transcriptional elongation by RNA polymerase II. Mol Cell Biol 23(12):4207–4218
Hamamoto R, Furukawa Y, Morita M, Iimura Y, Silva FP, Li M et al (2004) SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells. Nat Cell Biol 6(8):731–740
Brown MA, Sims RJ 3rd, Gottlieb PD, Tucker PW (2006) Identification and characterization of Smyd2: a split SET/MYND domain-containing histone H3 lysine 36-specific methyltransferase that interacts with the Sin3 histone deacetylase complex. Mol Cancer 5:26
Lacoste N, Utley RT, Hunter JM, Poirier GG, Cote J (2002) Disruptor of telomeric silencing-1 is a chromatin-specific histone H3 methyltransferase. J Biol Chem 277(34):30421–30424
Feng Q, Wang H, Ng HH, Erdjument-Bromage H, Tempst P, Struhl K et al (2002) Methylation of H3-lysine 79 is mediated by a new family of HMTases without a SET domain. Curr Biol 12(12):1052–1058
Yang H, Pesavento JJ, Starnes TW, Cryderman DE, Wallrath LL, Kelleher NL et al (2008) Preferential dimethylation of histone H4 lysine 20 by Suv4-20. J Biol Chem 283(18):12085–12092
Schotta G, Lachner M, Sarma K, Ebert A, Sengupta R, Reuter G et al (2004) A silencing pathway to induce H3-K9 and H4-K20 trimethylation at constitutive heterochromatin. Genes Dev 18(11):1251–1262
Sakaguchi A, Karachentsev D, Seth-Pasricha M, Druzhinina M, Steward R (2008) Functional characterization of the Drosophila Hmt4-20/Suv4-20 histone methyltransferase. Genetics 179(1):317–322
Cao R, Zhang Y (2004) SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EED-EZH2 complex. Mol Cell 15(1):57–67
Hohenauer T, Moore AW (2012) The Prdm family: expanding roles in stem cells and development. Development 139(13):2267–2282
Yi X, Jiang XJ, Li XY, Jiang DS (2015) Histone methyltransferases: novel targets for tumor and developmental defects. Am J Transl Res 7(11):2159–2175
Schultz DC, Ayyanathan K, Negorev D, Maul GG, Rauscher FJ 3rd (2002) SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins. Genes Dev 16(8):919–932
Rice JC, Briggs SD, Ueberheide B, Barber CM, Shabanowitz J, Hunt DF et al (2003) Histone methyltransferases direct different degrees of methylation to define distinct chromatin domains. Mol Cell 12(6):1591–1598
Tachibana M, Ueda J, Fukuda M, Takeda N, Ohta T, Iwanari H et al (2005) Histone methyltransferases G9a and GLP form heteromeric complexes and are both crucial for methylation of euchromatin at H3-K9. Genes Dev 19(7):815–826
Nielsen PR, Nietlispach D, Mott HR, Callaghan J, Bannister A, Kouzarides T et al (2002) Structure of the HP1 chromodomain bound to histone H3 methylated at lysine 9. Nature 416(6876):103–107
Fischle W, Wang Y, Jacobs SA, Kim Y, Allis CD, Khorasanizadeh S (2003) Molecular basis for the discrimination of repressive methyl-lysine marks in histone H3 by Polycomb and HP1 chromodomains. Genes Dev 17(15):1870–1881
Sampath SC, Marazzi I, Yap KL, Sampath SC, Krutchinsky AN, Mecklenbrauker I et al (2007) Methylation of a histone mimic within the histone methyltransferase G9a regulates protein complex assembly. Mol Cell 27(4):596–608
Peters AH, O’Carroll D, Scherthan H, Mechtler K, Sauer S, Schofer C et al (2001) Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability. Cell 107(3):323–337
Garcia-Cao M, O’Sullivan R, Peters AH, Jenuwein T, Blasco MA (2004) Epigenetic regulation of telomere length in mammalian cells by the Suv39h1 and Suv39h2 histone methyltransferases. Nat Genet 36(1):94–99
Peters AH, Kubicek S, Mechtler K, O’Sullivan RJ, Derijck AA, Perez-Burgos L et al (2003) Partitioning and plasticity of repressive histone methylation states in mammalian chromatin. Mol Cell 12(6):1577–1589
Tachibana M, Sugimoto K, Nozaki M, Ueda J, Ohta T, Ohki M et al (2002) G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis. Genes Dev 16(14):1779–1791
Wagschal A, Sutherland HG, Woodfine K, Henckel A, Chebli K, Schulz R et al (2008) G9a histone methyltransferase contributes to imprinting in the mouse placenta. Mol Cell Biol 28(3):1104–1113
Rathert P, Dhayalan A, Murakami M, Zhang X, Tamas R, Jurkowska R et al (2008) Protein lysine methyltransferase G9a acts on non-histone targets. Nat Chem Biol 4(6):344–346
Ogawa H, Ishiguro K, Gaubatz S, Livingston DM, Nakatani Y (2002) A complex with chromatin modifiers that occupies E2F- and Myc-responsive genes in G0 cells. Science 296(5570):1132–1136
Bian C, Chen Q, Yu X (2015) The zinc finger proteins ZNF644 and WIZ regulate the G9a/GLP complex for gene repression. Elife 4
Wang H, An W, Cao R, Xia L, Erdjument-Bromage H, Chatton B et al (2003) mAM facilitates conversion by ESET of dimethyl to trimethyl lysine 9 of histone H3 to cause transcriptional repression. Mol Cell 12(2):475–487
Falandry C, Fourel G, Galy V, Ristriani T, Horard B, Bensimon E et al (2010) CLLD8/KMT1F is a lysine methyltransferase that is important for chromosome segregation. J Biol Chem 285(26):20234–20241
Clouaire T, de Las Heras JI, Merusi C, Stancheva I (2010) Recruitment of MBD1 to target genes requires sequence-specific interaction of the MBD domain with methylated DNA. Nucleic Acids Res 38(14):4620–4634
Dodge JE, Kang YK, Beppu H, Lei H, Li E (2004) Histone H3-K9 methyltransferase ESET is essential for early development. Mol Cell Biol 24(6):2478–2486
Matsui T, Leung D, Miyashita H, Maksakova IA, Miyachi H, Kimura H et al (2010) Proviral silencing in embryonic stem cells requires the histone methyltransferase ESET. Nature 464(7290):927–931
Karimi MM, Goyal P, Maksakova IA, Bilenky M, Leung D, Tang JX et al (2011) DNA methylation and SETDB1/H3K9me3 regulate predominantly distinct sets of genes, retroelements, and chimeric transcripts in mESCs. Cell Stem Cell 8(6):676–687
Cosgrove MS, Patel A (2010) Mixed lineage leukemia: a structure-function perspective of the MLL1 protein. FEBS J 277(8):1832–1842
Ansari KI, Mandal SS (2010) Mixed lineage leukemia: roles in gene expression, hormone signaling and mRNA processing. FEBS J 277(8):1790–1804
Lee MG, Villa R, Trojer P, Norman J, Yan KP, Reinberg D et al (2007) Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination. Science 318(5849):447–450
Krivtsov AV, Armstrong SA (2007) MLL translocations, histone modifications and leukaemia stem-cell development. Nat Rev Cancer 7(11):823–833
Malik S, Bhaumik SR (2010) Mixed lineage leukemia: histone H3 lysine 4 methyltransferases from yeast to human. FEBS J 277(8):1805–1821
Dou Y, Milne TA, Ruthenburg AJ, Lee S, Lee JW, Verdine GL et al (2006) Regulation of MLL1 H3K4 methyltransferase activity by its core components. Nat Struct Mol Biol 13(8):713–719
Keogh MC, Kurdistani SK, Morris SA, Ahn SH, Podolny V, Collins SR et al (2005) Cotranscriptional set2 methylation of histone H3 lysine 36 recruits a repressive Rpd3 complex. Cell 123(4):593–605
Carrozza MJ, Li B, Florens L, Suganuma T, Swanson SK, Lee KK et al (2005) Histone H3 methylation by Set2 directs deacetylation of coding regions by Rpd3S to suppress spurious intragenic transcription. Cell 123(4):581–592
Wang GG, Cai L, Pasillas MP, Kamps MP (2007) NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis. Nat Cell Biol 9(7):804–812
Rayasam GV, Wendling O, Angrand PO, Mark M, Niederreither K, Song L et al (2003) NSD1 is essential for early post-implantation development and has a catalytically active SET domain. EMBO J 22(12):3153–3163
Schneider R, Bannister AJ, Kouzarides T (2002) Unsafe SETs: histone lysine methyltransferases and cancer. Trends Biochem Sci 27(8):396–402
Abu-Farha M, Lambert JP, Al-Madhoun AS, Elisma F, Skerjanc IS, Figeys D (2008) The tale of two domains: proteomics and genomics analysis of SMYD2, a new histone methyltransferase. Mol Cell Proteomics 7(3):560–572
Gottlieb PD, Pierce SA, Sims RJ, Yamagishi H, Weihe EK, Harriss JV et al (2002) Bop encodes a muscle-restricted protein containing MYND and SET domains and is essential for cardiac differentiation and morphogenesis. Nat Genet 31(1):25–32
Singer MS, Kahana A, Wolf AJ, Meisinger LL, Peterson SE, Goggin C et al (1998) Identification of high-copy disruptors of telomeric silencing in Saccharomyces cerevisiae. Genetics 150(2):613–632
Zee BM, Levin RS, Xu B, LeRoy G, Wingreen NS, Garcia BA (2010) In vivo residue-specific histone methylation dynamics. J Biol Chem 285(5):3341–3350
Jones B, Su H, Bhat A, Lei H, Bajko J, Hevi S et al (2008) The histone H3K79 methyltransferase Dot1L is essential for mammalian development and heterochromatin structure. PLoS Genet 4(9):e1000190
Anglin JL, Song Y (2013) A medicinal chemistry perspective for targeting histone H3 lysine-79 methyltransferase DOT1L. J Med Chem 56(22):8972–8983
Karachentsev D, Sarma K, Reinberg D, Steward R (2005) PR-Set7-dependent methylation of histone H4 Lys 20 functions in repression of gene expression and is essential for mitosis. Genes Dev 19(4):431–435
Li Z, Nie F, Wang S, Li L (2011) Histone H4 Lys 20 monomethylation by histone methylase SET8 mediates Wnt target gene activation. Proc Natl Acad Sci U S A 108(8):3116–3123
Tardat M, Brustel J, Kirsh O, Lefevbre C, Callanan M, Sardet C et al (2010) The histone H4 Lys 20 methyltransferase PR-Set7 regulates replication origins in mammalian cells. Nat Cell Biol 12(11):1086–1093
Jorgensen S, Eskildsen M, Fugger K, Hansen L, Larsen MS, Kousholt AN et al (2011) SET8 is degraded via PCNA-coupled CRL4(CDT2) ubiquitylation in S phase and after UV irradiation. J Cell Biol 192(1):43–54
Jorgensen S, Elvers I, Trelle MB, Menzel T, Eskildsen M, Jensen ON et al (2007) The histone methyltransferase SET8 is required for S-phase progression. J Cell Biol 179(7):1337–1345
Huen MS, Sy SM, van Deursen JM, Chen J (2008) Direct interaction between SET8 and proliferating cell nuclear antigen couples H4-K20 methylation with DNA replication. J Biol Chem 283(17):11073–11077
Centore RC, Havens CG, Manning AL, Li JM, Flynn RL, Tse A et al (2010) CRL4(Cdt2)-mediated destruction of the histone methyltransferase Set8 prevents premature chromatin compaction in S phase. Mol Cell 40(1):22–33
Abbas T, Shibata E, Park J, Jha S, Karnani N, Dutta A (2010) CRL4(Cdt2) regulates cell proliferation and histone gene expression by targeting PR-Set7/Set8 for degradation. Mol Cell 40(1):9–21
Schotta G, Sengupta R, Kubicek S, Malin S, Kauer M, Callen E et al (2008) A chromatin-wide transition to H4K20 monomethylation impairs genome integrity and programmed DNA rearrangements in the mouse. Genes Dev 22(15):2048–2061
Botuyan MV, Lee J, Ward IM, Kim JE, Thompson JR, Chen J et al (2006) Structural basis for the methylation state-specific recognition of histone H4-K20 by 53BP1 and Crb2 in DNA repair. Cell 127(7):1361–1373
Margueron R, Reinberg D (2011) The Polycomb complex PRC2 and its mark in life. Nature 469(7330):343–349
Kuzmichev A, Nishioka K, Erdjument-Bromage H, Tempst P, Reinberg D (2002) Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein. Genes Dev 16(22):2893–2905
Cao R, Wang L, Wang H, Xia L, Erdjument-Bromage H, Tempst P et al (2002) Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Science 298(5595):1039–1043
Schmitges FW, Prusty AB, Faty M, Stutzer A, Lingaraju GM, Aiwazian J et al (2011) Histone methylation by PRC2 is inhibited by active chromatin marks. Mol Cell 42(3):330–341
Wu H, Chen X, Xiong J, Li Y, Li H, Ding X et al (2011) Histone methyltransferase G9a contributes to H3K27 methylation in vivo. Cell Res 21(2):365–367
Mozzetta C, Pontis J, Fritsch L, Robin P, Portoso M, Proux C et al (2014) The histone H3 lysine 9 methyltransferases G9a and GLP regulate polycomb repressive complex 2-mediated gene silencing. Mol Cell 53(2):277–289
Martin-Perez D, Piris MA, Sanchez-Beato M (2010) Polycomb proteins in hematologic malignancies. Blood 116(25):5465–5475
Ezhkova E, Pasolli HA, Parker JS, Stokes N, Su IH, Hannon G et al (2009) Ezh2 orchestrates gene expression for the stepwise differentiation of tissue-specific stem cells. Cell 136(6):1122–1135
Shen X, Liu Y, Hsu YJ, Fujiwara Y, Kim J, Mao X et al (2008) EZH1 mediates methylation on histone H3 lysine 27 and complements EZH2 in maintaining stem cell identity and executing pluripotency. Mol Cell 32(4):491–502
Nishioka K, Chuikov S, Sarma K, Erdjument-Bromage H, Allis CD, Tempst P et al (2002) Set9, a novel histone H3 methyltransferase that facilitates transcription by precluding histone tail modifications required for heterochromatin formation. Genes Dev 16(4):479–489
Pradhan S, Chin HG, Esteve PO, Jacobsen SE (2009) SET7/9 mediated methylation of non-histone proteins in mammalian cells. Epigenetics 4(6):383–387
Wang J, Hevi S, Kurash JK, Lei H, Gay F, Bajko J et al (2009) The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation. Nat Genet 41(1):125–129
Couture JF, Collazo E, Hauk G, Trievel RC (2006) Structural basis for the methylation site specificity of SET7/9. Nat Struct Mol Biol 13(2):140–146
Abbondanza C, Medici N, Nigro V, Rossi V, Gallo L, Piluso G et al (2000) The retinoblastoma-interacting zinc-finger protein RIZ is a downstream effector of estrogen action. Proc Natl Acad Sci U S A 97(7):3130–3135
Fumasoni I, Meani N, Rambaldi D, Scafetta G, Alcalay M, Ciccarelli FD (2007) Family expansion and gene rearrangements contributed to the functional specialization of PRDM genes in vertebrates. BMC Evol Biol 7:187
Pinheiro I, Margueron R, Shukeir N, Eisold M, Fritzsch C, Richter FM et al (2012) Prdm3 and Prdm16 are H3K9me1 methyltransferases required for mammalian heterochromatin integrity. Cell 150(5):948–960
Trojer P, Zhang J, Yonezawa M, Schmidt A, Zheng H, Jenuwein T et al (2009) Dynamic Histone H1 Isotype 4 Methylation and Demethylation by Histone Lysine Methyltransferase G9a/KMT1C and the Jumonji Domain-containing JMJD2/KDM4 Proteins. J Biol Chem 284(13):8395–8405
Melcher M, Schmid M, Aagaard L, Selenko P, Laible G, Jenuwein T (2000) Structure-function analysis of SUV39H1 reveals a dominant role in heterochromatin organization, chromosome segregation, and mitotic progression. Mol Cell Biol 20(10):3728–3741
Wen B, Wu H, Shinkai Y, Irizarry RA, Feinberg AP (2009) Large histone H3 lysine 9 dimethylated chromatin blocks distinguish differentiated from embryonic stem cells. Nat Genet 41(2):246–250
Guelen L, Pagie L, Brasset E, Meuleman W, Faza MB, Talhout W et al (2008) Domain organization of human chromosomes revealed by mapping of nuclear lamina interactions. Nature 453(7197):948–951
Towbin BD, Gonzalez-Aguilera C, Sack R, Gaidatzis D, Kalck V, Meister P et al (2012) Step-wise methylation of histone H3K9 positions heterochromatin at the nuclear periphery. Cell 150(5):934–947
Kind J, Pagie L, Ortabozkoyun H, Boyle S, de Vries SS, Janssen H et al (2013) Single-cell dynamics of genome-nuclear lamina interactions. Cell 153(1):178–192
Yokochi T, Poduch K, Ryba T, Lu J, Hiratani I, Tachibana M et al (2009) G9a selectively represses a class of late-replicating genes at the nuclear periphery. Proc Natl Acad Sci U S A 106(46):19363–19368
Ambler RP, Rees MW (1959) Epsilon-N-Methyl-lysine in bacterial flagellar protein. Nature 184:56–57
Murray K (1964) The occurrence of epsilon-N-methyl lysine in histones. Biochemistry 3:10–15
Tong SW, Elzinga M (1983) The sequence of the NH2-terminal 204-residue fragment of the heavy chain of rabbit skeletal muscle myosin. J Biol Chem 258(21):13100–13110
L’Italien JJ, Laursen RA (1979) Location of the site of methylation in elongation factor Tu. FEBS Lett 107(2):359–362
Hardy MF, Perry SV (1969) In vitro methylation of muscle proteins. Nature 223(5203):300–302
Hardy M, Harris I, Perry SV, Stone D (1970) Epsilon-N-monomethyl-lysine and trimethyl-lysine in myosin. Biochem J 117(2):44P–45P
DeLange RJ, Glazer AN, Smith EL (1969) Presence and location of an unusual amino acid, epsilon-N-trimethyllysine, in cytochrome c of wheat germ and Neurospora. J Biol Chem 244(5):1385–1388
Bloxham DP, Parmelee DC, Kumar S, Wade RD, Ericsson LH, Neurath H et al (1981) Primary structure of porcine heart citrate synthase. Proc Natl Acad Sci U S A 78(9):5381–5385
Ames GF, Niakido K (1979) In vivo methylation of prokaryotic elongation factor Tu. J Biol Chem 254(20):9947–9950
Dhami GK, Liu H, Galka M, Voss C, Wei R, Muranko K et al (2013) Dynamic methylation of Numb by Set8 regulates its binding to p53 and apoptosis. Mol Cell 50(4):565–576
Levy D, Kuo AJ, Chang Y, Schaefer U, Kitson C, Cheung P et al (2011) Lysine methylation of the NF-kappaB subunit RelA by SETD6 couples activity of the histone methyltransferase GLP at chromatin to tonic repression of NF-kappaB signaling. Nat Immunol 12(1):29–36
Tuzon CT, Spektor T, Kong X, Congdon LM, Wu S, Schotta G et al (2014) Concerted activities of distinct H4K20 methyltransferases at DNA double-strand breaks regulate 53BP1 nucleation and NHEJ-directed repair. Cell Rep 8(2):430–438
Boisvert FM, Rhie A, Richard S, Doherty AJ (2005) The GAR motif of 53BP1 is arginine methylated by PRMT1 and is necessary for 53BP1 DNA binding activity. Cell Cycle 4(12):1834–1841
Liu H, Galka M, Mori E, Liu X, Lin YF, Wei R et al (2013) A method for systematic mapping of protein lysine methylation identifies functions for HP1beta in DNA damage response. Mol Cell 50(5):723–735
Guo A, Gu H, Zhou J, Mulhern D, Wang Y, Lee KA et al (2014) Immunoaffinity enrichment and mass spectrometry analysis of protein methylation. Mol Cell Proteomics 13(1):372–387
Choudhary C, Weinert BT, Nishida Y, Verdin E, Mann M (2014) The growing landscape of lysine acetylation links metabolism and cell signalling. Nat Rev Mol Cell Biol 15(8):536–550
Carlson SM, Moore KE, Green EM, Martin GM, Gozani O (2014) Proteome-wide enrichment of proteins modified by lysine methylation. Nat Protoc 9(1):37–50
Hornbeck PV, Kornhauser JM, Tkachev S, Zhang B, Skrzypek E, Murray B et al (2012) PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse. Nucleic Acids Res 40(Database issue):D261–D270
Biggar KK, Li SS (2015) Non-histone protein methylation as a regulator of cellular signalling and function. Nat Rev Mol Cell Biol 16(1):5–17
Mazur PK, Reynoird N, Khatri P, Jansen PW, Wilkinson AW, Liu S et al (2014) SMYD3 links lysine methylation of MAP3K2 to Ras-driven cancer. Nature 510(7504):283–287
Yang Y, Bedford MT (2013) Protein arginine methyltransferases and cancer. Nat Rev Cancer 13(1):37–50
Thinnes CC, England KS, Kawamura A, Chowdhury R, Schofield CJ, Hopkinson RJ (2014) Targeting histone lysine demethylases - progress, challenges, and the future. Biochim Biophys Acta 1839(12):1416–1432
Varier RA, Timmers HT (2011) Histone lysine methylation and demethylation pathways in cancer. Biochim Biophys Acta 1815(1):75–89
Huang J, Sengupta R, Espejo AB, Lee MG, Dorsey JA, Richter M et al (2007) p53 is regulated by the lysine demethylase LSD1. Nature 449(7158):105–108
Cui G, Park S, Badeaux AI, Kim D, Lee J, Thompson JR et al (2012) PHF20 is an effector protein of p53 double lysine methylation that stabilizes and activates p53. Nat Struct Mol Biol 19(9):916–924
Ivanov GS, Ivanova T, Kurash J, Ivanov A, Chuikov S, Gizatullin F et al (2007) Methylation-acetylation interplay activates p53 in response to DNA damage. Mol Cell Biol 27(19):6756–6769
Chuikov S, Kurash JK, Wilson JR, Xiao B, Justin N, Ivanov GS et al (2004) Regulation of p53 activity through lysine methylation. Nature 432(7015):353–360
Campaner S, Spreafico F, Burgold T, Doni M, Rosato U, Amati B et al (2011) The methyltransferase Set7/9 (Setd7) is dispensable for the p53-mediated DNA damage response in vivo. Mol Cell 43(4):681–688
Huang J, Dorsey J, Chuikov S, Perez-Burgos L, Zhang X, Jenuwein T et al (2010) G9a and Glp methylate lysine 373 in the tumor suppressor p53. J Biol Chem 285(13):9636–9641
Chen L, Li Z, Zwolinska AK, Smith MA, Cross B, Koomen J et al (2010) MDM2 recruitment of lysine methyltransferases regulates p53 transcriptional output. EMBO J 29(15):2538–2552
Shi X, Kachirskaia I, Yamaguchi H, West LE, Wen H, Wang EW et al (2007) Modulation of p53 function by SET8-mediated methylation at lysine 382. Mol Cell 27(4):636–646
Munro S, Khaire N, Inche A, Carr S, La Thangue NB (2010) Lysine methylation regulates the pRb tumour suppressor protein. Oncogene 29(16):2357–2367
Carr SM, Munro S, Kessler B, Oppermann U, La Thangue NB (2011) Interplay between lysine methylation and Cdk phosphorylation in growth control by the retinoblastoma protein. EMBO J 30(2):317–327
Saddic LA, West LE, Aslanian A, Yates JR 3rd, Rubin SM, Gozani O et al (2010) Methylation of the retinoblastoma tumor suppressor by SMYD2. J Biol Chem 285(48):37733–37740
Cho Y, Turner ND, Davidson LA, Chapkin RS, Carroll RJ, Lupton JR (2012) A chemoprotective fish oil/pectin diet enhances apoptosis via Bcl-2 promoter methylation in rat azoxymethane-induced carcinomas. Exp Biol Med 237(12):1387–1393
Kontaki H, Talianidis I (2010) Lysine methylation regulates E2F1-induced cell death. Mol Cell 39(1):152–160
Ea CK, Baltimore D (2009) Regulation of NF-kappaB activity through lysine monomethylation of p65. Proc Natl Acad Sci U S A 106(45):18972–18977
Yang XD, Huang B, Li M, Lamb A, Kelleher NL, Chen LF (2009) Negative regulation of NF-kappaB action by Set9-mediated lysine methylation of the RelA subunit. EMBO J 28(8):1055–1066
Lu T, Jackson MW, Wang B, Yang M, Chance MR, Miyagi M et al (2010) Regulation of NF-kappaB by NSD1/FBXL11-dependent reversible lysine methylation of p65. Proc Natl Acad Sci U S A 107(1):46–51
Kouskouti A, Scheer E, Staub A, Tora L, Talianidis I (2004) Gene-specific modulation of TAF10 function by SET9-mediated methylation. Mol Cell 14(2):175–182
Yang J, Huang J, Dasgupta M, Sears N, Miyagi M, Wang B et al (2010) Reversible methylation of promoter-bound STAT3 by histone-modifying enzymes. Proc Natl Acad Sci U S A 107(50):21499–21504
Kim E, Kim M, Woo DH, Shin Y, Shin J, Chang N et al (2013) Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells. Cancer Cell 23(6):839–852
Xie Q, Hao Y, Tao L, Peng S, Rao C, Chen H et al (2012) Lysine methylation of FOXO3 regulates oxidative stress-induced neuronal cell death. EMBO Rep 13(4):371–377
Oudhoff MJ, Freeman SA, Couzens AL, Antignano F, Kuznetsova E, Min PH et al (2013) Control of the hippo pathway by Set7-dependent methylation of Yap. Dev Cell 26(2):188–194
He A, Shen X, Ma Q, Cao J, von Gise A, Zhou P et al (2012) PRC2 directly methylates GATA4 and represses its transcriptional activity. Genes Dev 26(1):37–42
Choi SY, Jang H, Roe JS, Kim ST, Cho EJ, Youn HD (2013) Phosphorylation and ubiquitination-dependent degradation of CABIN1 releases p53 for transactivation upon genotoxic stress. Nucleic Acids Res 41(4):2180–2190
Ling BM, Bharathy N, Chung TK, Kok WK, Li S, Tan YH et al (2012) Lysine methyltransferase G9a methylates the transcription factor MyoD and regulates skeletal muscle differentiation. Proc Natl Acad Sci U S A 109(3):841–846
Pless O, Kowenz-Leutz E, Knoblich M, Lausen J, Beyermann M, Walsh MJ et al (2008) G9a-mediated lysine methylation alters the function of CCAAT/enhancer-binding protein-beta. J Biol Chem 283(39):26357–26363
Lee JS, Kim Y, Kim IS, Kim B, Choi HJ, Lee JM et al (2010) Negative regulation of hypoxic responses via induced Reptin methylation. Mol Cell 39(1):71–85
Nair SS, Li DQ, Kumar R (2013) A core chromatin remodeling factor instructs global chromatin signaling through multivalent reading of nucleosome codes. Mol Cell 49(4):704–718
Lee JM, Lee JS, Kim H, Kim K, Park H, Kim JY et al (2012) EZH2 generates a methyl degron that is recognized by the DCAF1/DDB1/CUL4 E3 ubiquitin ligase complex. Mol Cell 48(4):572–586
Cho HS, Suzuki T, Dohmae N, Hayami S, Unoki M, Yoshimatsu M et al (2011) Demethylation of RB regulator MYPT1 by histone demethylase LSD1 promotes cell cycle progression in cancer cells. Cancer Res 71(3):655–660
Dhayalan A, Kudithipudi S, Rathert P, Jeltsch A (2011) Specificity analysis-based identification of new methylation targets of the SET7/9 protein lysine methyltransferase. Chem Biol 18(1):111–120
Ko S, Ahn J, Song CS, Kim S, Knapczyk-Stwora K, Chatterjee B (2011) Lysine methylation and functional modulation of androgen receptor by Set9 methyltransferase. Mol Endocrinol 25(3):433–444
Balasubramaniyan N, Ananthanarayanan M, Suchy FJ (2012) Direct methylation of FXR by Set7/9, a lysine methyltransferase, regulates the expression of FXR target genes. Am J Physiol Gastrointest Liver Physiol 302(9):G937–G947
Subramanian K, Jia D, Kapoor-Vazirani P, Powell DR, Collins RE, Sharma D et al (2008) Regulation of estrogen receptor alpha by the SET7 lysine methyltransferase. Mol Cell 30(3):336–347
Hwang YJ, Han D, Kim KY, Min SJ, Kowall NW, Yang L et al (2014) ESET methylates UBF at K232/254 and regulates nucleolar heterochromatin plasticity and rDNA transcription. Nucleic Acids Res 42(3):1628–1643
Esteve PO, Chin HG, Benner J, Feehery GR, Samaranayake M, Horwitz GA et al (2009) Regulation of DNMT1 stability through SET7-mediated lysine methylation in mammalian cells. Proc Natl Acad Sci U S A 106(13):5076–5081
Chang Y, Sun L, Kokura K, Horton JR, Fukuda M, Espejo A et al (2011) MPP8 mediates the interactions between DNA methyltransferase Dnmt3a and H3K9 methyltransferase GLP/G9a. Nat Commun 2:533
Wang D, Zhou J, Liu X, Lu D, Shen C, Du Y et al (2013) Methylation of SUV39H1 by SET7/9 results in heterochromatin relaxation and genome instability. Proc Natl Acad Sci U S A 110(14):5516–5521
Chin HG, Esteve PO, Pradhan M, Benner J, Patnaik D, Carey MF et al (2007) Automethylation of G9a and its implication in wider substrate specificity and HP1 binding. Nucleic Acids Res 35(21):7313–7323
Masatsugu T, Yamamoto K (2009) Multiple lysine methylation of PCAF by Set9 methyltransferase. Biochem Biophys Res Commun 381(1):22–26
Liu L, Sun B, Pedersen JN, Aw Yong KM, Getzenberg RH, Stone HA et al (2011) Probing the invasiveness of prostate cancer cells in a 3D microfabricated landscape. Proc Natl Acad Sci U S A 108(17):6853–6856
Xu C, Bian C, Yang W, Galka M, Ouyang H, Chen C et al (2010) Binding of different histone marks differentially regulates the activity and specificity of polycomb repressive complex 2 (PRC2). Proc Natl Acad Sci U S A 107(45):19266–19271
Sewalt RG, Lachner M, Vargas M, Hamer KM, den Blaauwen JL, Hendrix T et al (2002) Selective interactions between vertebrate polycomb homologs and the SUV39H1 histone lysine methyltransferase suggest that histone H3-K9 methylation contributes to chromosomal targeting of Polycomb group proteins. Mol Cell Biol 22(15):5539–5553
Takawa M, Cho HS, Hayami S, Toyokawa G, Kogure M, Yamane Y et al (2012) Histone lysine methyltransferase SETD8 promotes carcinogenesis by deregulating PCNA expression. Cancer Res 72(13):3217–3227
Kassner I, Andersson A, Fey M, Tomas M, Ferrando-May E, Hottiger MO (2013) SET7/9-dependent methylation of ARTD1 at K508 stimulates poly-ADP-ribose formation after oxidative stress. Open Biol 3(10):120173
Cloutier P, Lavallee-Adam M, Faubert D, Blanchette M, Coulombe B (2013) A newly uncovered group of distantly related lysine methyltransferases preferentially interact with molecular chaperones to regulate their activity. PLoS Genet 9(1):e1003210
Kunizaki M, Hamamoto R, Silva FP, Yamaguchi K, Nagayasu T, Shibuya M et al (2007) The lysine 831 of vascular endothelial growth factor receptor 1 is a novel target of methylation by SMYD3. Cancer Res 67(22):10759–10765
Van Duyne R, Easley R, Wu W, Berro R, Pedati C, Klase Z et al (2008) Lysine methylation of HIV-1 Tat regulates transcriptional activity of the viral LTR. Retrovirology 5:40
Pagans S, Kauder SE, Kaehlcke K, Sakane N, Schroeder S, Dormeyer W et al (2010) The Cellular lysine methyltransferase Set7/9-KMT7 binds HIV-1 TAR RNA, monomethylates the viral transactivator Tat, and enhances HIV transcription. Cell Host Microbe 7(3):234–244
Abu-Farha M, Lanouette S, Elisma F, Tremblay V, Butson J, Figeys D et al (2011) Proteomic analyses of the SMYD family interactomes identify HSP90 as a novel target for SMYD2. J Mol Cell Biol 3(5):301–308
Cho HS, Shimazu T, Toyokawa G, Daigo Y, Maehara Y, Hayami S et al (2012) Enhanced HSP70 lysine methylation promotes proliferation of cancer cells through activation of Aurora kinase B. Nat Commun 3:1072
Levy D, Liu CL, Yang Z, Newman AM, Alizadeh AA, Utz PJ et al (2011) A proteomic approach for the identification of novel lysine methyltransferase substrates. Epigenetics Chromatin 4:19
Sitaramayya A, Wright LS, Siegel FL (1980) Enzymatic methylation of calmodulin in rat brain cytosol. J Biol Chem 255(18):8894–8900
Lübbert M, Jones PA (2013) Epigenetic therapy of cancer: preclinical models and treatment approaches. Springer, Berlin/Heidelberg
Kubicek S, O’Sullivan RJ, August EM, Hickey ER, Zhang Q, Teodoro ML et al (2007) Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase. Mol Cell 25(3):473–481
Weidinger G (1995) Pharmacokinetic and pharmacodynamic properties and therapeutic use of bunazosin in hypertension. A review. Arzneimittelforschung 45(11):1166–1171
Liu F, Chen X, Allali-Hassani A, Quinn AM, Wasney GA, Dong A et al (2009) Discovery of a 2,4-diamino-7-aminoalkoxyquinazoline as a potent and selective inhibitor of histone lysine methyltransferase G9a. J Med Chem 52(24):7950–7953
Vedadi M, Barsyte-Lovejoy D, Liu F, Rival-Gervier S, Allali-Hassani A, Labrie V et al (2011) A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells. Nat Chem Biol 7(8):566–574
Chang Y, Ganesh T, Horton JR, Spannhoff A, Liu J, Sun A et al (2010) Adding a lysine mimic in the design of potent inhibitors of histone lysine methyltransferases. J Mol Biol 400(1):1–7
Liu F, Barsyte-Lovejoy D, Li F, Xiong Y, Korboukh V, Huang XP et al (2013) Discovery of an in vivo chemical probe of the lysine methyltransferases G9a and GLP. J Med Chem 56(21):8931–8942
Pappano WN, Guo J, He Y, Ferguson D, Jagadeeswaran S, Osterling DJ et al (2015) The Histone Methyltransferase Inhibitor A-366 Uncovers a Role for G9a/GLP in the Epigenetics of Leukemia. PLoS One 10(7):e0131716
Yuan Y, Wang Q, Paulk J, Kubicek S, Kemp MM, Adams DJ et al (2012) A small-molecule probe of the histone methyltransferase G9a induces cellular senescence in pancreatic adenocarcinoma. ACS Chem Biol 7(7):1152–1157
Miranda TB, Cortez CC, Yoo CB, Liang G, Abe M, Kelly TK et al (2009) DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation. Mol Cancer Ther 8(6):1579–1588
Knutson SK, Wigle TJ, Warholic NM, Sneeringer CJ, Allain CJ, Klaus CR et al (2012) A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells. Nat Chem Biol 8(11):890–896
McCabe MT, Ott HM, Ganji G, Korenchuk S, Thompson C, Van Aller GS et al (2012) EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations. Nature 492(7427):108–112
Daigle SR, Olhava EJ, Therkelsen CA, Majer CR, Sneeringer CJ, Song J et al (2011) Selective killing of mixed lineage leukemia cells by a potent small-molecule DOT1L inhibitor. Cancer Cell 20(1):53–65
Ferguson AD, Larsen NA, Howard T, Pollard H, Green I, Grande C et al (2011) Structural basis of substrate methylation and inhibition of SMYD2. Structure 19(9):1262–1273
Nguyen KT, Li F, Poda G, Smil D, Vedadi M, Schapira M (2013) Strategy to target the substrate binding site of SET domain protein methyltransferases. J Chem Inf Model 53(3):681–691
Simon JA, Lange CA (2008) Roles of the EZH2 histone methyltransferase in cancer epigenetics. Mutat Res 647(1-2):21–29
Kleer CG, Cao Q, Varambally S, Shen R, Ota I, Tomlins SA et al (2003) EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc Natl Acad Sci U S A 100(20):11606–11611
Kang MY, Lee BB, Kim YH, Chang DK, Kyu Park S, Chun HK et al (2007) Association of the SUV39H1 histone methyltransferase with the DNA methyltransferase 1 at mRNA expression level in primary colorectal cancer. Int J Cancer 121(10):2192–2197
O’Carroll D, Scherthan H, Peters AH, Opravil S, Haynes AR, Laible G et al (2000) Isolation and characterization of Suv39h2, a second histone H3 methyltransferase gene that displays testis-specific expression. Mol Cell Biol 20(24):9423–9433
Gu Y, Nakamura T, Alder H, Prasad R, Canaani O, Cimino G et al (1992) The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene. Cell 71(4):701–708
Liedtke M, Cleary ML (2009) Therapeutic targeting of MLL. Blood 113(24):6061–6068
Tkachuk DC, Kohler S, Cleary ML (1992) Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias. Cell 71(4):691–700
Bitoun E, Oliver PL, Davies KE (2007) The mixed-lineage leukemia fusion partner AF4 stimulates RNA polymerase II transcriptional elongation and mediates coordinated chromatin remodeling. Hum Mol Genet 16(1):92–106
Okada Y, Feng Q, Lin Y, Jiang Q, Li Y, Coffield VM et al (2005) hDOT1L links histone methylation to leukemogenesis. Cell 121(2):167–178
Kim JY, Kee HJ, Choe NW, Kim SM, Eom GH, Baek HJ et al (2008) Multiple-myeloma-related WHSC1/MMSET isoform RE-IIBP is a histone methyltransferase with transcriptional repression activity. Mol Cell Biol 28(6):2023–2034
Lauring J, Abukhdeir AM, Konishi H, Garay JP, Gustin JP, Wang Q et al (2008) The multiple myeloma associated MMSET gene contributes to cellular adhesion, clonogenic growth, and tumorigenicity. Blood 111(2):856–864
Angrand PO, Apiou F, Stewart AF, Dutrillaux B, Losson R, Chambon P (2001) NSD3, a new SET domain-containing gene, maps to 8p12 and is amplified in human breast cancer cell lines. Genomics 74(1):79–88
Rosati R, La Starza R, Veronese A, Aventin A, Schwienbacher C, Vallespi T et al (2002) NUP98 is fused to the NSD3 gene in acute myeloid leukemia associated with t(8;11)(p11.2;p15). Blood 99(10):3857–3860
Hamamoto R, Silva FP, Tsuge M, Nishidate T, Katagiri T, Nakamura Y et al (2006) Enhanced SMYD3 expression is essential for the growth of breast cancer cells. Cancer Sci 97(2):113–118
Cho HS, Kelly JD, Hayami S, Toyokawa G, Takawa M, Yoshimatsu M et al (2011) Enhanced expression of EHMT2 is involved in the proliferation of cancer cells through negative regulation of SIAH1. Neoplasia 13(8):676–684
Kondo Y, Shen L, Ahmed S, Boumber Y, Sekido Y, Haddad BR et al (2008) Downregulation of histone H3 lysine 9 methyltransferase G9a induces centrosome disruption and chromosome instability in cancer cells. PLoS One 3(4):e2037
Chen H, Yan Y, Davidson TL, Shinkai Y, Costa M (2006) Hypoxic stress induces dimethylated histone H3 lysine 9 through histone methyltransferase G9a in mammalian cells. Cancer Res 66(18):9009–9016
Pereira JD, Sansom SN, Smith J, Dobenecker MW, Tarakhovsky A, Livesey FJ (2010) Ezh2, the histone methyltransferase of PRC2, regulates the balance between self-renewal and differentiation in the cerebral cortex. Proc Natl Acad Sci U S A 107(36):15957–15962
Sher F, Rossler R, Brouwer N, Balasubramaniyan V, Boddeke E, Copray S (2008) Differentiation of neural stem cells into oligodendrocytes: involvement of the polycomb group protein Ezh2. Stem Cells 26(11):2875–2883
Lim DA, Huang YC, Swigut T, Mirick AL, Garcia-Verdugo JM, Wysocka J et al (2009) Chromatin remodelling factor Mll1 is essential for neurogenesis from postnatal neural stem cells. Nature 458(7237):529–533
Jepsen K, Solum D, Zhou T, McEvilly RJ, Kim HJ, Glass CK et al (2007) SMRT-mediated repression of an H3K27 demethylase in progression from neural stem cell to neuron. Nature 450(7168):415–419
Burgold T, Spreafico F, De Santa F, Totaro MG, Prosperini E, Natoli G et al (2008) The histone H3 lysine 27-specific demethylase Jmjd3 is required for neural commitment. PLoS One 3(8):e3034
Tahiliani M, Mei P, Fang R, Leonor T, Rutenberg M, Shimizu F et al (2007) The histone H3K4 demethylase SMCX links REST target genes to X-linked mental retardation. Nature 447(7144):601–605
Kerimoglu C, Agis-Balboa RC, Kranz A, Stilling R, Bahari-Javan S, Benito-Garagorri E et al (2013) Histone-methyltransferase MLL2 (KMT2B) is required for memory formation in mice. J Neurosci 33(8):3452–3464
Gupta S, Kim SY, Artis S, Molfese DL, Schumacher A, Sweatt JD et al (2010) Histone methylation regulates memory formation. J Neurosci 30(10):3589–3599
Gupta-Agarwal S, Franklin AV, Deramus T, Wheelock M, Davis RL, McMahon LL et al (2012) G9a/GLP histone lysine dimethyltransferase complex activity in the hippocampus and the entorhinal cortex is required for gene activation and silencing during memory consolidation. J Neurosci 32(16):5440–5453
Schaefer A, Sampath SC, Intrator A, Min A, Gertler TS, Surmeier DJ et al (2009) Control of cognition and adaptive behavior by the GLP/G9a epigenetic suppressor complex. Neuron 64(5):678–691
Shinkai Y, Tachibana M (2011) H3K9 methyltransferase G9a and the related molecule GLP. Genes Dev 25(8):781–788
Tzeng TY, Lee CH, Chan LW, Shen CK (2007) Epigenetic regulation of the Drosophila chromosome 4 by the histone H3K9 methyltransferase dSETDB1. Proc Natl Acad Sci U S A 104(31):12691–12696
Kleefstra T, Brunner HG, Amiel J, Oudakker AR, Nillesen WM, Magee A et al (2006) Loss-of-function mutations in euchromatin histone methyl transferase 1 (EHMT1) cause the 9q34 subtelomeric deletion syndrome. Am J Hum Genet 79(2):370–377
Kleefstra T, Smidt M, Banning MJ, Oudakker AR, Van Esch H, de Brouwer AP et al (2005) Disruption of the gene Euchromatin Histone Methyl Transferase1 (Eu-HMTase1) is associated with the 9q34 subtelomeric deletion syndrome. J Med Genet 42(4):299–306
Nillesen WM, Yntema HG, Moscarda M, Verbeek NE, Wilson LC, Cowan F et al (2011) Characterization of a novel transcript of the EHMT1 gene reveals important diagnostic implications for Kleefstra syndrome. Hum Mutat 32(7):853–859
Balemans MC, Huibers MM, Eikelenboom NW, Kuipers AJ, van Summeren RC, Pijpers MM et al (2010) Reduced exploration, increased anxiety, and altered social behavior: Autistic-like features of euchromatin histone methyltransferase 1 heterozygous knockout mice. Behav Brain Res 208(1):47–55
Maze I, Covington HE 3rd, Dietz DM, LaPlant Q, Renthal W, Russo SJ et al (2010) Essential role of the histone methyltransferase G9a in cocaine-induced plasticity. Science 327(5962):213–216
Benevento M, Iacono G, Selten M, Ba W, Oudakker A, Frega M et al (2016) Histone Methylation by the Kleefstra Syndrome Protein EHMT1 Mediates Homeostatic Synaptic Scaling. Neuron 91(2):341–355
Ryu H, Lee J, Hagerty SW, Soh BY, McAlpin SE, Cormier KA et al (2006) ESET/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington’s disease. Proc Natl Acad Sci U S A 103(50):19176–19181
Li J, Hart RP, Mallimo EM, Swerdel MR, Kusnecov AW, Herrup K (2013) EZH2-mediated H3K27 trimethylation mediates neurodegeneration in ataxia-telangiectasia. Nat Neurosci 16(12):1745–1753
Chouliaras L, Rutten BP, Kenis G, Peerbooms O, Visser PJ, Verhey F et al (2010) Epigenetic regulation in the pathophysiology of Alzheimer’s disease. Prog Neurobiol 90(4):498–510
Kelly TK, De Carvalho DD, Jones PA (2010) Epigenetic modifications as therapeutic targets. Nat Biotechnol 28(10):1069–1078
Kouzarides T (2007) Chromatin modifications and their function. Cell 128(4):693–705
Wu JI, Lessard J, Crabtree GR (2009) Understanding the words of chromatin regulation. Cell 136(2):200–206
Kimura M, Koseki Y, Yamashita M, Watanabe N, Shimizu C, Katsumoto T et al (2001) Regulation of Th2 cell differentiation by mel-18, a mammalian polycomb group gene. Immunity 15(2):275–287
Koyanagi M, Baguet A, Martens J, Margueron R, Jenuwein T, Bix M (2005) EZH2 and histone 3 trimethyl lysine 27 associated with Il4 and Il13 gene silencing in Th1 cells. J Biol Chem 280(36):31470–31477
Yamashita M, Hirahara K, Shinnakasu R, Hosokawa H, Norikane S, Kimura MY et al (2006) Crucial role of MLL for the maintenance of memory T helper type 2 cell responses. Immunity 24(5):611–622
Yamashita M, Shinnakasu R, Nigo Y, Kimura M, Hasegawa A, Taniguchi M et al (2004) Interleukin (IL)-4-independent maintenance of histone modification of the IL-4 gene loci in memory Th2 cells. J Biol Chem 279(38):39454–39464
Araki Y, Wang Z, Zang C, Wood WH 3rd, Schones D, Cui K et al (2009) Genome-wide analysis of histone methylation reveals chromatin state-based regulation of gene transcription and function of memory CD8+ T cells. Immunity 30(6):912–925
Wei G, Wei L, Zhu J, Zang C, Hu-Li J, Yao Z et al (2009) Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. Immunity 30(1):155–167
Allan RS, Zueva E, Cammas F, Schreiber HA, Masson V, Belz GT et al (2012) An epigenetic silencing pathway controlling T helper 2 cell lineage commitment. Nature 487(7406):249–253
Suzuki A, Iwamura C, Shinoda K, Tumes DJ, Kimura MY, Hosokawa H et al (2010) Polycomb group gene product Ring1B regulates Th2-driven airway inflammation through the inhibition of Bim-mediated apoptosis of effector Th2 cells in the lung. J Immunol 184(8):4510–4520
Yamashita M, Kuwahara M, Suzuki A, Hirahara K, Shinnaksu R, Hosokawa H et al (2008) Bmi1 regulates memory CD4 T cell survival via repression of the Noxa gene. J Exp Med 205(5):1109–1120
Lehnertz B, Northrop JP, Antignano F, Burrows K, Hadidi S, Mullaly SC et al (2010) Activating and inhibitory functions for the histone lysine methyltransferase G9a in T helper cell differentiation and function. J Exp Med 207(5):915–922
Min J, Zaslavsky A, Fedele G, McLaughlin SK, Reczek EE, De Raedt T et al (2010) An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-kappaB. Nat Med 16(3):286–294
Vire E, Brenner C, Deplus R, Blanchon L, Fraga M, Didelot C et al (2006) The Polycomb group protein EZH2 directly controls DNA methylation. Nature 439(7078):871–874
Xia M, Liu J, Wu X, Liu S, Li G, Han C et al (2013) Histone methyltransferase Ash1l suppresses interleukin-6 production and inflammatory autoimmune diseases by inducing the ubiquitin-editing enzyme A20. Immunity 39(3):470–481
Ohkura N, Hamaguchi M, Morikawa H, Sugimura K, Tanaka A, Ito Y et al (2012) T cell receptor stimulation-induced epigenetic changes and Foxp3 expression are independent and complementary events required for Treg cell development. Immunity 37(5):785–799
Bannister AJ, Schneider R, Myers FA, Thorne AW, Crane-Robinson C, Kouzarides T (2005) Spatial distribution of di- and tri-methyl lysine 36 of histone H3 at active genes. J Biol Chem 280(18):17732–17736
Schuettengruber B, Chourrout D, Vervoort M, Leblanc B, Cavalli G (2007) Genome regulation by polycomb and trithorax proteins. Cell 128(4):735–745
Hong SH, Rampalli S, Lee JB, McNicol J, Collins T, Draper JS et al (2011) Cell fate potential of human pluripotent stem cells is encoded by histone modifications. Cell Stem Cell 9(1):24–36
Paige SL, Thomas S, Stoick-Cooper CL, Wang H, Maves L, Sandstrom R et al (2012) A temporal chromatin signature in human embryonic stem cells identifies regulators of cardiac development. Cell 151(1):221–232
Xie R, Everett LJ, Lim HW, Patel NA, Schug J, Kroon E et al (2013) Dynamic chromatin remodeling mediated by polycomb proteins orchestrates pancreatic differentiation of human embryonic stem cells. Cell Stem Cell 12(2):224–237
Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, Cuff J et al (2006) A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125(2):315–326
Hawkins RD, Hon GC, Lee LK, Ngo Q, Lister R, Pelizzola M et al (2010) Distinct epigenomic landscapes of pluripotent and lineage-committed human cells. Cell Stem Cell 6(5):479–491
Zhu J, Adli M, Zou JY, Verstappen G, Coyne M, Zhang X et al (2013) Genome-wide chromatin state transitions associated with developmental and environmental cues. Cell 152(3):642–654
Ang YS, Tsai SY, Lee DF, Monk J, Su J, Ratnakumar K et al (2011) Wdr5 mediates self-renewal and reprogramming via the embryonic stem cell core transcriptional network. Cell 145(2):183–197
Ding X, Wang X, Sontag S, Qin J, Wanek P, Lin Q et al (2014) The polycomb protein Ezh2 impacts on induced pluripotent stem cell generation. Stem Cells Dev 23(9):931–940
Onder TT, Kara N, Cherry A, Sinha AU, Zhu N, Bernt KM et al (2012) Chromatin-modifying enzymes as modulators of reprogramming. Nature 483(7391):598–602
Pereira CF, Piccolo FM, Tsubouchi T, Sauer S, Ryan NK, Bruno L et al (2010) ESCs require PRC2 to direct the successful reprogramming of differentiated cells toward pluripotency. Cell Stem Cell 6(6):547–556
Rao RA, Dhele N, Cheemadan S, Ketkar A, Jayandharan GR, Palakodeti D et al (2015) Ezh2 mediated H3K27me3 activity facilitates somatic transition during human pluripotent reprogramming. Sci Rep 5:8229
Huangfu D, Maehr R, Guo W, Eijkelenboom A, Snitow M, Chen AE et al (2008) Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat Biotechnol 26(7):795–797
Shi Y, Do JT, Desponts C, Hahm HS, Scholer HR, Ding S (2008) A combined chemical and genetic approach for the generation of induced pluripotent stem cells. Cell Stem Cell 2(6):525–528
Ma DK, Chiang CH, Ponnusamy K, Ming GL, Song H (2008) G9a and Jhdm2a regulate embryonic stem cell fusion-induced reprogramming of adult neural stem cells. Stem Cells 26(8):2131–2141
Inagawa M, Nakajima K, Makino T, Ogawa S, Kojima M, Ito S et al (2013) Histone H3 lysine 9 methyltransferases, G9a and GLP are essential for cardiac morphogenesis. Mech Dev 130(11-12):519–531
Katoh K, Yamazaki R, Onishi A, Sanuki R, Furukawa T (2012) G9a histone methyltransferase activity in retinal progenitors is essential for proper differentiation and survival of mouse retinal cells. J Neurosci 32(49):17658–17670
Ohno H, Shinoda K, Ohyama K, Sharp LZ, Kajimura S (2013) EHMT1 controls brown adipose cell fate and thermogenesis through the PRDM16 complex. Nature 504(7478):163–167
Tachibana M, Nozaki M, Takeda N, Shinkai Y (2007) Functional dynamics of H3K9 methylation during meiotic prophase progression. EMBO J 26(14):3346–3359
Wang L, Xu S, Lee JE, Baldridge A, Grullon S, Peng W et al (2013) Histone H3K9 methyltransferase G9a represses PPARgamma expression and adipogenesis. EMBO J 32(1):45–59
Epsztejn-Litman S, Feldman N, Abu-Remaileh M, Shufaro Y, Gerson A, Ueda J et al (2008) De novo DNA methylation promoted by G9a prevents reprogramming of embryonically silenced genes. Nat Struct Mol Biol 15(11):1176–1183
Feldman N, Gerson A, Fang J, Li E, Zhang Y, Shinkai Y et al (2006) G9a-mediated irreversible epigenetic inactivation of Oct-3/4 during early embryogenesis. Nat Cell Biol 8(2):188–194
Yamamizu K, Fujihara M, Tachibana M, Katayama S, Takahashi A, Hara E et al (2012) Protein kinase A determines timing of early differentiation through epigenetic regulation with G9a. Cell Stem Cell 10(6):759–770
Chen X, Skutt-Kakaria K, Davison J, Ou YL, Choi E, Malik P et al (2012) G9a/GLP-dependent histone H3K9me2 patterning during human hematopoietic stem cell lineage commitment. Genes Dev 26(22):2499–2511
Liu N, Zhang Z, Wu H, Jiang Y, Meng L, Xiong J et al (2015) Recognition of H3K9 methylation by GLP is required for efficient establishment of H3K9 methylation, rapid target gene repression, and mouse viability. Genes Dev 29(4):379–393
Di Lorenzo A, Bedford MT (2011) Histone arginine methylation. FEBS Lett 585(13):2024–2031
Fuhrmann J, Clancy KW, Thompson PR (2015) Chemical biology of protein arginine modifications in epigenetic regulation. Chem Rev 115(11):5413–5461
Jenuwein T, Allis CD (2001) Translating the histone code. Science 293(5532):1074–1080
Strahl BD, Allis CD (2000) The language of covalent histone modifications. Nature 403(6765):41–45
Branscombe TL, Frankel A, Lee JH, Cook JR, Yang Z, Pestka S et al (2001) PRMT5 (Janus kinase-binding protein 1) catalyzes the formation of symmetric dimethylarginine residues in proteins. J Biol Chem 276(35):32971–32976
Yang Y, Hadjikyriacou A, Xia Z, Gayatri S, Kim D, Zurita-Lopez C et al (2015) PRMT9 is a type II methyltransferase that methylates the splicing factor SAP145. Nat Commun 6:6428
Feng Y, Maity R, Whitelegge JP, Hadjikyriacou A, Li Z, Zurita-Lopez C et al (2013) Mammalian protein arginine methyltransferase 7 (PRMT7) specifically targets RXR sites in lysine- and arginine-rich regions. J Biol Chem 288(52):37010–37025
Gayatri S, Bedford MT (2014) Readers of histone methylarginine marks. Biochim Biophys Acta 1839(8):702–710
Bedford MT (2007) Arginine methylation at a glance. J Cell Sci 120(Pt 24):4243–4246
Gary JD, Clarke S (1998) RNA and protein interactions modulated by protein arginine methylation. Prog Nucleic Acid Res Mol Biol 61:65–131
Bedford MT, Clarke SG (2009) Protein arginine methylation in mammals: who, what, and why. Mol Cell 33(1):1–13
Lee DY, Teyssier C, Strahl BD, Stallcup MR (2005) Role of protein methylation in regulation of transcription. Endocr Rev 26(2):147–170
Lajer M, Tarnow L, Jorsal A, Teerlink T, Parving HH, Rossing P (2008) Plasma concentration of asymmetric dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy. Diabetes Care 31(4):747–752
Lin WJ, Gary JD, Yang MC, Clarke S, Herschman HR (1996) The mammalian immediate-early TIS21 protein and the leukemia-associated BTG1 protein interact with a protein-arginine N-methyltransferase. J Biol Chem 271(25):15034–15044
Tang J, Frankel A, Cook RJ, Kim S, Paik WK, Williams KR et al (2000) PRMT1 is the predominant type I protein arginine methyltransferase in mammalian cells. J Biol Chem 275(11):7723–7730
Pawlak MR, Scherer CA, Chen J, Roshon MJ, Ruley HE (2000) Arginine N-methyltransferase 1 is required for early postimplantation mouse development, but cells deficient in the enzyme are viable. Mol Cell Biol 20(13):4859–4869
Wang H, Huang ZQ, Xia L, Feng Q, Erdjument-Bromage H, Strahl BD et al (2001) Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor. Science 293(5531):853–857
An W, Kim J, Roeder RG (2004) Ordered cooperative functions of PRMT1, p300, and CARM1 in transcriptional activation by p53. Cell 117(6):735–748
Boisvert FM, Dery U, Masson JY, Richard S (2005) Arginine methylation of MRE11 by PRMT1 is required for DNA damage checkpoint control. Genes Dev 19(6):671–676
Sun Q, Liu L, Roth M, Tian J, He Q, Zhong B et al (2015) PRMT1 Upregulated by Epithelial Proinflammatory Cytokines Participates in COX2 Expression in Fibroblasts and Chronic Antigen-Induced Pulmonary Inflammation. J Immunol 195(1):298–306
Raptis V, Kapoulas S, Grekas D (2013) Role of asymmetrical dimethylarginine in the progression of renal disease. Nephrology 18(1):11–21
Scott HS, Antonarakis SE, Lalioti MD, Rossier C, Silver PA, Henry MF (1998) Identification and characterization of two putative human arginine methyltransferases (HRMT1L1 and HRMT1L2). Genomics 48(3):330–340
Sayegh J, Webb K, Cheng D, Bedford MT, Clarke SG (2007) Regulation of protein arginine methyltransferase 8 (PRMT8) activity by its N-terminal domain. J Biol Chem 282(50):36444–36453
Lakowski TM, Frankel A (2009) Kinetic analysis of human protein arginine N-methyltransferase 2: formation of monomethyl- and asymmetric dimethyl-arginine residues on histone H4. Biochem J 421(2):253–261
Meyer R, Wolf SS, Obendorf M (2007) PRMT2, a member of the protein arginine methyltransferase family, is a coactivator of the androgen receptor. J Steroid Biochem Mol Biol 107(1-2):1–14
Qi C, Chang J, Zhu Y, Yeldandi AV, Rao SM, Zhu YJ (2002) Identification of protein arginine methyltransferase 2 as a coactivator for estrogen receptor alpha. J Biol Chem 277(32):28624–28630
Ganesh L, Yoshimoto T, Moorthy NC, Akahata W, Boehm M, Nabel EG et al (2006) Protein methyltransferase 2 inhibits NF-kappaB function and promotes apoptosis. Mol Cell Biol 26(10):3864–3874
Zhong J, Cao RX, Hong T, Yang J, Zu XY, Xiao XH et al (2011) Identification and expression analysis of a novel transcript of the human PRMT2 gene resulted from alternative polyadenylation in breast cancer. Gene 487(1):1–9
Yildirim AO, Bulau P, Zakrzewicz D, Kitowska KE, Weissmann N, Grimminger F et al (2006) Increased protein arginine methylation in chronic hypoxia: role of protein arginine methyltransferases. Am J Respir Cell Mol Biol 35(4):436–443
Tang J, Gary JD, Clarke S, Herschman HR (1998) PRMT 3, a type I protein arginine N-methyltransferase that differs from PRMT1 in its oligomerization, subcellular localization, substrate specificity, and regulation. J Biol Chem 273(27):16935–16945
Swiercz R, Person MD, Bedford MT (2005) Ribosomal protein S2 is a substrate for mammalian PRMT3 (protein arginine methyltransferase 3). Biochem J 386(Pt 1):85–91
Chen X, Niroomand F, Liu Z, Zankl A, Katus HA, Jahn L et al (2006) Expression of nitric oxide related enzymes in coronary heart disease. Basic Res Cardiol 101(4):346–353
Matsuguma K, Ueda S, Yamagishi S, Matsumoto Y, Kaneyuki U, Shibata R et al (2006) Molecular mechanism for elevation of asymmetric dimethylarginine and its role for hypertension in chronic kidney disease. J Am Soc Nephrol 17(8):2176–2183
Chen D, Ma H, Hong H, Koh SS, Huang SM, Schurter BT et al (1999) Regulation of transcription by a protein methyltransferase. Science 284(5423):2174–2177
Cheng D, Cote J, Shaaban S, Bedford MT (2007) The arginine methyltransferase CARM1 regulates the coupling of transcription and mRNA processing. Mol Cell 25(1):71–83
Yadav N, Lee J, Kim J, Shen J, Hu MC, Aldaz CM et al (2003) Specific protein methylation defects and gene expression perturbations in coactivator-associated arginine methyltransferase 1-deficient mice. Proc Natl Acad Sci U S A 100(11):6464–6468
Kim J, Lee J, Yadav N, Wu Q, Carter C, Richard S et al (2004) Loss of CARM1 results in hypomethylation of thymocyte cyclic AMP-regulated phosphoprotein and deregulated early T cell development. J Biol Chem 279(24):25339–25344
Yadav N, Cheng D, Richard S, Morel M, Iyer VR, Aldaz CM et al (2008) CARM1 promotes adipocyte differentiation by coactivating PPARgamma. EMBO Rep 9(2):193–198
Ito T, Yadav N, Lee J, Furumatsu T, Yamashita S, Yoshida K et al (2009) Arginine methyltransferase CARM1/PRMT4 regulates endochondral ossification. BMC Dev Biol 9:47
O’Brien KB, Alberich-Jorda M, Yadav N, Kocher O, Diruscio A, Ebralidze A et al (2010) CARM1 is required for proper control of proliferation and differentiation of pulmonary epithelial cells. Development 137(13):2147–2156
Fabbrizio E, El Messaoudi S, Polanowska J, Paul C, Cook JR, Lee JH et al (2002) Negative regulation of transcription by the type II arginine methyltransferase PRMT5. EMBO Rep 3(7):641–645
Pollack BP, Kotenko SV, He W, Izotova LS, Barnoski BL, Pestka S (1999) The human homologue of the yeast proteins Skb1 and Hsl7p interacts with Jak kinases and contains protein methyltransferase activity. J Biol Chem 274(44):31531–31542
Lacroix M, El Messaoudi S, Rodier G, Le Cam A, Sardet C, Fabbrizio E (2008) The histone-binding protein COPR5 is required for nuclear functions of the protein arginine methyltransferase PRMT5. EMBO Rep 9(5):452–458
Hou Z, Peng H, Ayyanathan K, Yan KP, Langer EM, Longmore GD et al (2008) The LIM protein AJUBA recruits protein arginine methyltransferase 5 to mediate SNAIL-dependent transcriptional repression. Mol Cell Biol 28(10):3198–3207
Cesaro E, De Cegli R, Medugno L, Florio F, Grosso M, Lupo A et al (2009) The Kruppel-like zinc finger protein ZNF224 recruits the arginine methyltransferase PRMT5 on the transcriptional repressor complex of the aldolase A gene. J Biol Chem 284(47):32321–32330
Tabata T, Kokura K, Ten Dijke P, Ishii S (2009) Ski co-repressor complexes maintain the basal repressed state of the TGF-beta target gene, SMAD7, via HDAC3 and PRMT5. Genes Cells 14(1):17–28
Rank G, Cerruti L, Simpson RJ, Moritz RL, Jane SM, Zhao Q (2010) Identification of a PRMT5-dependent repressor complex linked to silencing of human fetal globin gene expression. Blood 116(9):1585–1592
Neuenkirchen N, Chari A, Fischer U (2008) Deciphering the assembly pathway of Sm-class U snRNPs. FEBS Lett 582(14):1997–2003
Vagin VV, Wohlschlegel J, Qu J, Jonsson Z, Huang X, Chuma S et al (2009) Proteomic analysis of murine Piwi proteins reveals a role for arginine methylation in specifying interaction with Tudor family members. Genes Dev 23(15):1749–1762
Gu Z, Li Y, Lee P, Liu T, Wan C, Wang Z (2012) Protein arginine methyltransferase 5 functions in opposite ways in the cytoplasm and nucleus of prostate cancer cells. PLoS One 7(8):e44033
Bode-Boger SM, Scalera F, Kielstein JT, Martens-Lobenhoffer J, Breithardt G, Fobker M et al (2006) Symmetrical dimethylarginine: a new combined parameter for renal function and extent of coronary artery disease. J Am Soc Nephrol 17(4):1128–1134
Ratovitski T, Arbez N, Stewart JC, Chighladze E, Ross CA (2015) PRMT5- mediated symmetric arginine dimethylation is attenuated by mutant huntingtin and is impaired in Huntington’s disease (HD). Cell Cycle 14(11):1716–1729
Quan X, Yue W, Luo Y, Cao J, Wang H, Wang Y et al (2015) The protein arginine methyltransferase PRMT5 regulates Abeta-induced toxicity in human cells and Caenorhabditis elegans models of Alzheimer’s disease. J Neurochem 134(5):969–977
Frankel A, Yadav N, Lee J, Branscombe TL, Clarke S, Bedford MT (2002) The novel human protein arginine N-methyltransferase PRMT6 is a nuclear enzyme displaying unique substrate specificity. J Biol Chem 277(5):3537–3543
Guccione E, Bassi C, Casadio F, Martinato F, Cesaroni M, Schuchlautz H et al (2007) Methylation of histone H3R2 by PRMT6 and H3K4 by an MLL complex are mutually exclusive. Nature 449(7164):933–937
Hyllus D, Stein C, Schnabel K, Schiltz E, Imhof A, Dou Y et al (2007) PRMT6-mediated methylation of R2 in histone H3 antagonizes H3 K4 trimethylation. Genes Dev 21(24):3369–3380
Michaud-Levesque J, Richard S (2009) Thrombospondin-1 is a transcriptional repression target of PRMT6. J Biol Chem 284(32):21338–21346
Xie B, Invernizzi CF, Richard S, Wainberg MA (2007) Arginine methylation of the human immunodeficiency virus type 1 Tat protein by PRMT6 negatively affects Tat Interactions with both cyclin T1 and the Tat transactivation region. J Virol 81(8):4226–4234
Zakrzewicz D, Zakrzewicz A, Preissner KT, Markart P, Wygrecka M (2012) Protein Arginine Methyltransferases (PRMTs): promising targets for the treatment of pulmonary disorders. Int J Mol Sci 13(10):12383–12400
Miranda TB, Miranda M, Frankel A, Clarke S (2004) PRMT7 is a member of the protein arginine methyltransferase family with a distinct substrate specificity. J Biol Chem 279(22):22902–22907
Bleibel WK, Duan S, Huang RS, Kistner EO, Shukla SJ, Wu X et al (2009) Identification of genomic regions contributing to etoposide-induced cytotoxicity. Hum Genet 125(2):173–180
Gros L, Delaporte C, Frey S, Decesse J, de Saint-Vincent BR, Cavarec L et al (2003) Identification of new drug sensitivity genes using genetic suppressor elements: protein arginine N-methyltransferase mediates cell sensitivity to DNA-damaging agents. Cancer Res 63(1):164–171
Verbiest V, Montaudon D, Tautu MT, Moukarzel J, Portail JP, Markovits J et al (2008) Protein arginine (N)-methyl transferase 7 (PRMT7) as a potential target for the sensitization of tumor cells to camptothecins. FEBS Lett 582(10):1483–1489
Zheng Z, Schmidt-Ott KM, Chua S, Foster KA, Frankel RZ, Pavlidis P et al (2005) A Mendelian locus on chromosome 16 determines susceptibility to doxorubicin nephropathy in the mouse. Proc Natl Acad Sci U S A 102(7):2502–2507
Jelinic P, Stehle JC, Shaw P (2006) The testis-specific factor CTCFL cooperates with the protein methyltransferase PRMT7 in H19 imprinting control region methylation. PLoS Biol 4(11):e355
Buhr N, Carapito C, Schaeffer C, Kieffer E, Van Dorsselaer A, Viville S (2008) Nuclear proteome analysis of undifferentiated mouse embryonic stem and germ cells. Electrophoresis 29(11):2381–2390
Yao R, Jiang H, Ma Y, Wang L, Wang L, Du J et al (2014) PRMT7 induces epithelial-to-mesenchymal transition and promotes metastasis in breast cancer. Cancer Res 74(19):5656–5667
Lee J, Sayegh J, Daniel J, Clarke S, Bedford MT (2005) PRMT8, a new membrane-bound tissue-specific member of the protein arginine methyltransferase family. J Biol Chem 280(38):32890–32896
Hung CM, Li C (2004) Identification and phylogenetic analyses of the protein arginine methyltransferase gene family in fish and ascidians. Gene 340(2):179–187
Andrade MA, Perez-Iratxeta C, Ponting CP (2001) Protein repeats: structures, functions, and evolution. J Struct Biol 134(2-3):117–131
Uhlen M, Fagerberg L, Hallstrom BM, Lindskog C, Oksvold P, Mardinoglu A et al (2015) Proteomics. Tissue-based map of the human proteome. Science 347(6220):1260419
Yost JM, Korboukh I, Liu F, Gao C, Jin J (2011) Targets in epigenetics: inhibiting the methyl writers of the histone code. Curr Chem Genom 5(Suppl 1):72–84
Vu LP, Perna F, Wang L, Voza F, Figueroa ME, Tempst P et al (2013) PRMT4 blocks myeloid differentiation by assembling a methyl-RUNX1-dependent repressor complex. Cell Rep 5(6):1625–1638
Zhao X, Jankovic V, Gural A, Huang G, Pardanani A, Menendez S et al (2008) Methylation of RUNX1 by PRMT1 abrogates SIN3A binding and potentiates its transcriptional activity. Genes Dev 22(5):640–653
Cho EC, Zheng S, Munro S, Liu G, Carr SM, Moehlenbrink J et al (2012) Arginine methylation controls growth regulation by E2F-1. EMBO J 31(7):1785–1797
Zheng S, Moehlenbrink J, Lu YC, Zalmas LP, Sagum CA, Carr S et al (2013) Arginine methylation-dependent reader-writer interplay governs growth control by E2F-1. Mol Cell 52(1):37–51
Mitchell TR, Glenfield K, Jeyanthan K, Zhu XD (2009) Arginine methylation regulates telomere length and stability. Mol Cell Biol 29(18):4918–4934
Tang J, Kao PN, Herschman HR (2000) Protein-arginine methyltransferase I, the predominant protein-arginine methyltransferase in cells, interacts with and is regulated by interleukin enhancer-binding factor 3. J Biol Chem 275(26):19866–19876
Le Romancer M, Treilleux I, Leconte N, Robin-Lespinasse Y, Sentis S, Bouchekioua-Bouzaghou K et al (2008) Regulation of estrogen rapid signaling through arginine methylation by PRMT1. Mol Cell 31(2):212–221
Jobert L, Argentini M, Tora L (2009) PRMT1 mediated methylation of TAF15 is required for its positive gene regulatory function. Exp Cell Res 315(7):1273–1286
Teyssier C, Le Romancer M, Sentis S, Jalaguier S, Corbo L, Cavailles V (2010) Protein arginine methylation in estrogen signaling and estrogen-related cancers. Trends Endocrinol Metab 21(3):181–189
Karkhanis V, Hu YJ, Baiocchi RA, Imbalzano AN, Sif S (2011) Versatility of PRMT5-induced methylation in growth control and development. Trends Biochem Sci 36(12):633–641
Bandyopadhyay S, Harris DP, Adams GN, Lause GE, McHugh A, Tillmaand EG et al (2012) HOXA9 methylation by PRMT5 is essential for endothelial cell expression of leukocyte adhesion molecules. Mol Cell Biol 32(7):1202–1213
Wei H, Wang B, Miyagi M, She Y, Gopalan B, Huang DB et al (2013) PRMT5 dimethylates R30 of the p65 subunit to activate NF-kappaB. Proc Natl Acad Sci U S A 110(33):13516–13521
Wang L, Zhao Z, Meyer MB, Saha S, Yu M, Guo A et al (2014) CARM1 methylates chromatin remodeling factor BAF155 to enhance tumor progression and metastasis. Cancer Cell 25(1):21–36
Sgarra R, Lee J, Tessari MA, Altamura S, Spolaore B, Giancotti V et al (2006) The AT-hook of the chromatin architectural transcription factor high mobility group A1a is arginine-methylated by protein arginine methyltransferase 6. J Biol Chem 281(7):3764–3772
El-Andaloussi N, Valovka T, Toueille M, Steinacher R, Focke F, Gehrig P et al (2006) Arginine methylation regulates DNA polymerase beta. Mol Cell 22(1):51–62
Lee J, Bedford MT (2002) PABP1 identified as an arginine methyltransferase substrate using high-density protein arrays. EMBO Rep 3(3):268–273
Yang M, Sun J, Sun X, Shen Q, Gao Z, Yang C (2009) Caenorhabditis elegans protein arginine methyltransferase PRMT-5 negatively regulates DNA damage-induced apoptosis. PLoS Genet 5(6):e1000514
Yamamoto T, Takano N, Ishiwata K, Ohmura M, Nagahata Y, Matsuura T et al (2014) Reduced methylation of PFKFB3 in cancer cells shunts glucose towards the pentose phosphate pathway. Nat Commun 5:3480
Buss H, Dorrie A, Schmitz ML, Frank R, Livingstone M, Resch K et al (2004) Phosphorylation of serine 468 by GSK-3beta negatively regulates basal p65 NF-kappaB activity. J Biol Chem 279(48):49571–49574
Boulanger MC, Liang C, Russell RS, Lin R, Bedford MT, Wainberg MA et al (2005) Methylation of Tat by PRMT6 regulates human immunodeficiency virus type 1 gene expression. J Virol 79(1):124–131
Abramovich C, Yakobson B, Chebath J, Revel M (1997) A protein-arginine methyltransferase binds to the intracytoplasmic domain of the IFNAR1 chain in the type I interferon receptor. EMBO J 16(2):260–266
Infantino S, Benz B, Waldmann T, Jung M, Schneider R, Reth M (2010) Arginine methylation of the B cell antigen receptor promotes differentiation. J Exp Med 207(4):711–719
Martin G, Ostareck-Lederer A, Chari A, Neuenkirchen N, Dettwiler S, Blank D et al (2010) Arginine methylation in subunits of mammalian pre-mRNA cleavage factor I. RNA 16(8):1646–1659
Baldwin GS, Carnegie PR (1971) Specific enzymic methylation of an arginine in the experimental allergic encephalomyelitis protein from human myelin. Science 171(3971):579–581
Butler JS, Zurita-Lopez CI, Clarke SG, Bedford MT, Dent SY (2011) Protein-arginine methyltransferase 1 (PRMT1) methylates Ash2L, a shared component of mammalian histone H3K4 methyltransferase complexes. J Biol Chem 286(14):12234–12244
Powers MA, Fay MM, Factor RE, Welm AL, Ullman KS (2011) Protein arginine methyltransferase 5 accelerates tumor growth by arginine methylation of the tumor suppressor programmed cell death 4. Cancer Res 71(16):5579–5587
Rajpurohit R, Lee SO, Park JO, Paik WK, Kim S (1994) Enzymatic methylation of recombinant heterogeneous nuclear RNP protein A1. Dual substrate specificity for S-adenosylmethionine:histone-arginine N-methyltransferase. J Biol Chem 269(2):1075–1082
Kwak YT, Guo J, Prajapati S, Park KJ, Surabhi RM, Miller B et al (2003) Methylation of SPT5 regulates its interaction with RNA polymerase II and transcriptional elongation properties. Mol Cell 11(4):1055–1066
Herrmann F, Bossert M, Schwander A, Akgun E, Fackelmayer FO (2004) Arginine methylation of scaffold attachment factor A by heterogeneous nuclear ribonucleoprotein particle-associated PRMT1. J Biol Chem 279(47):48774–48779
Dolzhanskaya N, Merz G, Denman RB (2006) Alternative splicing modulates protein arginine methyltransferase-dependent methylation of fragile X syndrome mental retardation protein. Biochemistry 45(34):10385–10393
Rho J, Choi S, Jung CR, Im DS (2007) Arginine methylation of Sam68 and SLM proteins negatively regulates their poly(U) RNA binding activity. Arch Biochem Biophys 466(1):49–57
Swiercz R, Cheng D, Kim D, Bedford MT (2007) Ribosomal protein rpS2 is hypomethylated in PRMT3-deficient mice. J Biol Chem 282(23):16917–16923
Brahms H, Raymackers J, Union A, de Keyser F, Meheus L, Luhrmann R (2000) The C-terminal RG dipeptide repeats of the spliceosomal Sm proteins D1 and D3 contain symmetrical dimethylarginines, which form a major B-cell epitope for anti-Sm autoantibodies. J Biol Chem 275(22):17122–17129
Shire K, Kapoor P, Jiang K, Hing MN, Sivachandran N, Nguyen T et al (2006) Regulation of the EBNA1 Epstein-Barr virus protein by serine phosphorylation and arginine methylation. J Virol 80(11):5261–5272
Barth S, Liss M, Voss MD, Dobner T, Fischer U, Meister G et al (2003) Epstein-Barr virus nuclear antigen 2 binds via its methylated arginine-glycine repeat to the survival motor neuron protein. J Virol 77(8):5008–5013
Kim JD, Kako K, Kakiuchi M, Park GG, Fukamizu A (2008) EWS is a substrate of type I protein arginine methyltransferase, PRMT8. Int J Mol Med 22(3):309–315
Cheng D, Yadav N, King RW, Swanson MS, Weinstein EJ, Bedford MT (2004) Small molecule regulators of protein arginine methyltransferases. J Biol Chem 279(23):23892–23899
Spannhoff A, Heinke R, Bauer I, Trojer P, Metzger E, Gust R et al (2007) Target-based approach to inhibitors of histone arginine methyltransferases. J Med Chem 50(10):2319–2325
Yu XR, Tang Y, Wang WJ, Ji S, Ma S, Zhong L et al (2015) Discovery and structure-activity analysis of 4-((5-nitropyrimidin-4-yl)amino)benzimidamide derivatives as novel protein arginine methyltransferase 1 (PRMT1) inhibitors. Bioorg Med Chem Lett 25(22):5449–5453
Spannhoff A, Machmur R, Heinke R, Trojer P, Bauer I, Brosch G et al (2007) A novel arginine methyltransferase inhibitor with cellular activity. Bioorg Med Chem Lett 17(15):4150–4153
Sinha SH, Owens EA, Feng Y, Yang Y, Xie Y, Tu Y et al (2012) Synthesis and evaluation of carbocyanine dyes as PRMT inhibitors and imaging agents. Eur J Med Chem 54:647–659
Yan L, Yan C, Qian K, Su H, Kofsky-Wofford SA, Lee WC et al (2014) Diamidine compounds for selective inhibition of protein arginine methyltransferase 1. J Med Chem 57(6):2611–2622
Purandare AV, Chen Z, Huynh T, Pang S, Geng J, Vaccaro W et al (2008) Pyrazole inhibitors of coactivator associated arginine methyltransferase 1 (CARM1). Bioorg Med Chem Lett 18(15):4438–4441
Henikoff S, Shilatifard A (2011) Histone modification: cause or cog? Trends Genet 27(10):389–396
Rathert P, Dhayalan A, Ma H, Jeltsch A (2008) Specificity of protein lysine methyltransferases and methods for detection of lysine methylation of non-histone proteins. Mol BioSyst 4(12):1186–1190
Wilhelm M, Schlegl J, Hahne H, Moghaddas Gholami A, Lieberenz M, Savitski MM et al (2014) Mass-spectrometry-based draft of the human proteome. Nature 509(7502):582–587
Moore KE, Carlson SM, Camp ND, Cheung P, James RG, Chua KF et al (2013) A general molecular affinity strategy for global detection and proteomic analysis of lysine methylation. Mol Cell 50(3):444–456
Ong SE, Mittler G, Mann M (2004) Identifying and quantifying in vivo methylation sites by heavy methyl SILAC. Nat Methods 1(2):119–126
Bremang M, Cuomo A, Agresta AM, Stugiewicz M, Spadotto V, Bonaldi T (2013) Mass spectrometry-based identification and characterisation of lysine and arginine methylation in the human proteome. Mol BioSyst 9(9):2231–2247
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Mohanty, A., Rampalli, S. (2018). SETting up Methylation in Mammalian Cells: Role of Histone Methyltransferases in Disease and Development. In: Jayandharan, G. (eds) Gene and Cell Therapy: Biology and Applications. Springer, Singapore. https://doi.org/10.1007/978-981-13-0481-1_7
Download citation
DOI: https://doi.org/10.1007/978-981-13-0481-1_7
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-0480-4
Online ISBN: 978-981-13-0481-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)